Taro Pharmaceuticals U.S.A., Inc.: Equate Athlete's Foot, Clotrimazole USP 1%, Antifungal Cream, Packaged as a) NET WT. 0.5 oz (14.2g), NDC 49035-812-01, b) NET WT 2 OZ (60g), NDC 49035-812-27. Distri

Is my product affected?

Equate Athlete's Foot, Clotrimazole USP 1%, Antifungal Cream, Packaged as a) NET WT. 0.5 oz (14.2g), NDC 49035-812-01, b) NET WT 2 OZ (60g), NDC 49035-812-27. Distributed by: Walmart Inc., Bentonville, AR 72716.

• Brand CLOTRIMAZOLE

Check against the official notice below — it lists the full affected range.

What happened

Taro Pharmaceuticals U.S.A., Inc. recalled Equate Athlete's Foot Clotrimazole USP 1% Antifungal Cream in two sizes: 0.5 oz (14.2g) tubes and 2 oz (60g) tubes. The recall affects approximately 481,896 tubes distributed nationwide in the USA and Canada. An unknown degradation impurity was detected slightly above specification limits in the product.

The affected lots include multiple batches with expiration dates ranging from December 2020 through February 2021. The specific lot numbers are: for the 0.5 oz size—A873430371 (Dec 2020), B870030918 (Jan 2021), and C868330918 (Feb 2021); for the 2 oz size—A873430406, A873530406, and A873630406 (all Dec 2020), B870030635 and B870130867 (Jan 2021), and C868330867 (Feb 2021). The source does not specify a remedy or action for consumers to take.

Written by software from the official notice below. Not reviewed by a lawyer.

Hazard

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Details from the source

Reason for recall: Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%. Distribution: Distributed Nationwide in the USA and Canada Quantity: 481,896 tubes Lot/code info: Lot#: a)A873430371, Exp Dec-2020; B870030918, Exp Jan-2021; C868330918, Exp Feb-2021 b) A873430406, A873530406, A873630406, Exp Dec-2020;B870030635, B870130867, Exp Jan-2021; C868330867, Exp Feb-2021

Source

Official record: FDA (Drug enforcement) ↗

Republished from the official source above; details can change — the source record controls.

Related recalls

• Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories, FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054, NDC 0591-2245-22.2020-10-28
• Buffered Lidocaine HCl, 1%, 5 mL (10mg/mL) with Sodium Bicarbonate Injection for Local Anesthetic Use, 5 mL Single Dose Syringe, Rx Only SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 700040725092020-12-17
• Zerbaxa (ceftolozane and tazobactam) 1.5g per vial for injection, Single-Dose vial, Rx only, Manuf. for: Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc., NDC 67919-030-012020-12-21
• Oxycodone Hydrochloride Oral Solution, USP 5 mg/5mL unit dose cups, Rx Only, Genus Lifesciences Inc. NDC 64950-354-05 Case NDC: 64950-354-450(40 unit dose cups) Case NDC 64950-354-55 (50 unit dose cups)2020-12-23
• metformin HCL ER 500 mg, a) 30 tablets NDC: 72789-009-30; b) 60 tablets NDC: 72789-009-60; c) 90 tablets NDC: 72789-009-90; d) 180 tablets NDC: 72789-009-93 bottles, Rx only, Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 731272020-10-06

All FDA (Drug enforcement) recalls